CTRI/2023/07/055382已完成Unknown
An open label randomized single dose two treatment two way crossover oral bioavailability study of investigational product in healthy adult human participants under fasting conditions. - nil
YourZooki holdings Ltd0 个研究点目标入组 12 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Normal healthy adult male and female Human participants of age between 21-65 years with a Body Mass Index (BMI) range between 18.50 kg/m2 to 24.99 kg/m2.
- •2.Plasma Ascorbic acid at screening <75µmol/1.
- •3.Subject agrees avoid vitamin C containing medications and dietary supplements from screening until last visit.
- •4.Subject agrees to avoid high activity physical exercise 72.00 hours prior to last visit
- •5.Subjects who have no evidence of underlying disease during screening and check- in and whose screening is performed within 29 days of check in.
- •6.Subjects whose screening laboratory values are within normal limits or considered by the physician or principal/clinical investigator to be of no clinical significance.
- •7.Healthy as documented by the medical history, physical examination (including but may not be limited to an evaluation of the cardiovascular, gastrointestinal, respiratory, musculoskeletal and central nervous systems) and vital sign assessments.
- •8.Generally healthy as documented by 12-lead electrocardiogram (ECG), X-Ray and clinical laboratory assessments.
- •9.Non- smokers or ex-smokers. Ex-smokers are defined as someone who has completely stopped smoking for at least the past 03 months.
- •10.Willing to consume ova-lacto vegetarian diet.
- •11.Willing to comply to all requirements of this study protocol as well as instructed by the study personnel
- •12.Female subjects within normal limits or clinically non-significant laboratory evaluation results for FSH and LH.
- •13.Generally healthy as documented by gynecological examination and breast examination (for female subjects during Period-I check-in only).
- •14.Female subjects of childbearing potential;
- •a.Practicing an acceptable non-hormonal contraceptive method of birth control after consulting with principal investigator; and/or
- •b.Surgically sterile (bilateral tubal ligation)
排除标准
- •1.Evidence of allergy or known hypersensitivity to Vitamin C or other related drugs or other related drugs.
- •2.Subjects with hepatic encephalopathy, cholestasis, myasthenia, pre-existing liver disease, alcohol abuse, existing tinnitus, renal or liver impairment and pre-existing gallbladder disease.
- •3.Any major illness in the last three months or any significant ongoing chronic medical illness.
- •4.Any disease or condition which might compromise the haemopoeitic, gastrointestinal, renal, hepatic, cardiovascular, Musculoskeletal, respiratory, central nervous system, diabetes, psychosis or any other body system.
- •5.History of alcohol addiction or abuse.
- •6.Malabsorption syndrome that affects vitamin c metabolism.
- •7.Heart failure, angina pectoris, ventricular arrhythmias or atrial fibrillation with >100/min ventricular rate.
- •8.Gastrointestinal bleeding in past three months.
- •9.Uncontrolled diabetes mellitus.
- •10.Active psychiatric disorder, intention for suicidal, disorders with Unconsciousness.
- •11.Psychopathic disorder, lack of cooperation.
- •12.Chronic obstructive lung disease or active smoking (more than 2 cigarettes in the past 6 months)
- •13.Taking more than 100 mg vitamin C daily within 2 weeks to screening.
- •14.Consumption of caffeine and /or Xanthine containing products (i.e., coffee, tea, chocolate, and caffeine-containing sodas, colas, etc.), tobacco containing products for at least 24.00 hours prior to check-in and throughout the entire study
- •15.Consumption of grapefruit and its juice and poppy containing foods for at least 72.00 hours prior to check-in and throughout the study.
- •16.Subjects who taken any prescription medications, over the counter medicinal products, herbal medications within 14 days prior to study check in and throughout the study.
- •17.History of dehydration from diarrhea, vomiting or any other reason within a period of 24.00 hours prior to study check-in of each period.
- •18.An unusual or abnormal diet within 48.00 hours prior to study check-in of each period, for whatever reason e.g. because of fasting due to religious reasons.
- •19.Subject who had participated in any other study within the 90 days of check-in.
- •20.History of difficulty in swallowing.
- •21.Positive results for drugs of abuse (Marijuana-THC, amphetamine-AMP, barbiturates-BAR, cocaine-COC, benzodiazepines-BZD and morphine-MOR) in urine prior to check-in of this study period.
- •22.Positive results for alcohol breath test prior to check-in of any study period
研究者
相似试验
已完成
不适用
To evaluate pharmacokinetic parameter of Vitamin E 400 mg capsules of Troikaa Pharmaceuticals Ltd India with Evion capsules 400 mg of Merck Sereno India in normal healthy adult human subjectsCTRI/2020/03/023718Troikaa Pharmaceuticals Ltd
尚未招募
Unknown
A Bioequivalence Study of Capecitabine 500 mg with Xeloda 500 mg in Adult Cancer Patients Under Fed ConditioCTRI/2024/05/068024BIOPHARM SPA
已完成
Unknown
An single dose, two-treatment, two-way crossover study of study product containing glutathione, in healthy, adult, human subjects under fasting conditions.CTRI/2023/08/056674YourZooki holdings Ltd24
尚未招募
不适用
To estimate the blood concentrations of liposomal vitamin c 5ml/1000mg (test) comapared with non liposomal vitamin c 5ml/1000mg (reference) in healthy, adult, human subjects under fasting conditionsCTRI/2017/07/008953CureSupport
Unknown
1 期
A Single Dose Randomized Open-label Two-treatment, Four-period, Two-sequence, Replicate Crossover Bioequivalence Study of Generic Dabigatran Etexilate Capsules 150 mg and Reference Product Pradaxa in Healthy Thai Volunteers under Fasting Conditions and under Pre-treatment with Proton Pump InhibitorBioequivalence Study in Healthy Thai VolunteersDabigatran Etexilate Capsules 150 mg in Healthy Thai VolunteersTCTR20230317008International Bio Service Co.,Ltd.48